deltatrials

Hematopoietic and lymphoid cell neoplasm Trials in Rochester, United States

Conditions / Hematopoietic and lymphoid cell neoplasm / Rochester, United States

Hematopoietic and lymphoid cell neoplasm is a medical condition with active clinical research programs worldwide.

16 total trials for this combination

Showing top 10 of 16 trials

Trials

NCT ID Title Status Phase
NCT05364086 An Observational Research Study for Cancer Patients on Immune Checkpoint Inhibitors, DiRECT Study ACTIVE_NOT_RECRUITING
NCT03080883 Apixaban in Preventing Secondary Cancer Related Venous Thrombosis in Cancer Patients Who Have Completed Anticoagulation Therapy COMPLETED PHASE3
NCT02465060 Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) ACTIVE_NOT_RECRUITING
NCT01638533 Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver Dysfunction COMPLETED PHASE1
NCT01503515 Caspofungin Acetate, Fluconazole, or Voriconazole in Preventing Fungal Infections in Patients Following Donor Stem Cell Transplant COMPLETED PHASE3
NCT02717507 Carvedilol in Preventing Heart Failure in Childhood Cancer Survivors COMPLETED PHASE2
NCT04939090 Olanzapine Versus Megestrol Acetate for the Treatment of Loss of Appetite Among Advanced Cancer Patients RECRUITING PHASE3
NCT04089358 Mobile Health and Social Media Physical Activity Intervention Among Adolescent and Young Adult Childhood Cancer Survivors, the StepByStep Study ACTIVE_NOT_RECRUITING PHASE3
NCT02465060 Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) ACTIVE_NOT_RECRUITING
NCT02465060 Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) ACTIVE_NOT_RECRUITING

Related Pages